Evaluating the economic and patient-motivating value of enhanced telemedicine and mobile non-invasive testing technologies in improving NAFLD diagnosis and lowering rates of non-communicable disease.
The Surfers and our guest Dr. Manal Abdelmalek consider the economic costs and value of enhanced telemedicine and mobile “de-liver” testing technology and then move on to consider critical success factors in making these innovations patient-friendly and motivating patients to take advantage of them.